Gene expression profiling of clinical stages II and III breast cancer

Folgueira, M. A. A. K; Brentani, H; Katayama, M. L. H; Patrão, D. F. C; Carraro, D. M; Mourão Netto, M; Barbosa, E. M; Caldeira, J. R. F; Abreu, A. P. S; Lyra, E. C; Kaiano, J. H. L; Mota, L. D; Campos, A. H. J. F. M; Maciel, M. S; Dellamano, M; Caballero, O. L. S. D; Brentani, M. M.
Braz. j. med. biol. res ; 39(8): 1101-1113, Aug. 2006. tab
Artigo em Inglês | LILACS | ID: lil-433168

Documentos relacionados

  1. Bacteria in tumors "hit the road" together.
  2. Deciphering breast cancer: from biology to the clinic.
  3. Tissue-resident FOLR2<sup>+</sup> macrophages associate with CD8<sup>+</sup> T cell infiltration in human breast cancer.
  4. Tumor-resident intracellular microbiota promotes metastatic colonization in breast cancer.
  5. Architecture and topologies of gene regulatory networks associated with breast cancer, adjacent normal, and normal tissues.
  6. Homologous recombination deficiency reflects the heterogeneity and monitoring treatment response for patients with breast cancer.
  7. Classifying breast cancer subtypes on multi-omics data via sparse canonical correlation analysis and deep learning.
  8. De novo individualized disease modules reveal the synthetic penetrance of genes and inform personalized treatment regimens.
  9. Distinct breast cancer phenotypes in BRCA 1/2 carriers based on ER status.
  10. Estimating clinical risk in gene regions from population sequencing cohort data.